Papillary  ||| S:0 E:10 ||| JJ
renal  ||| S:10 E:16 ||| JJ
cell  ||| S:16 E:21 ||| NN
carcinoma  ||| S:21 E:31 ||| NN
with  ||| S:31 E:36 ||| IN
a  ||| S:36 E:38 ||| DT
somatic  ||| S:38 E:46 ||| JJ
mutation  ||| S:46 E:55 ||| NN
in  ||| S:55 E:58 ||| IN
MET  ||| S:58 E:62 ||| NNP
in  ||| S:62 E:65 ||| IN
a  ||| S:65 E:67 ||| DT
patient  ||| S:67 E:75 ||| NN
with  ||| S:75 E:80 ||| IN
autosomal  ||| S:80 E:90 ||| FW
dominant  ||| S:90 E:99 ||| FW
polycystic  ||| S:99 E:110 ||| FW
kidney  ||| S:110 E:117 ||| FW
disease  ||| S:117 E:125 ||| FW
Autosomal-dominant  ||| S:125 E:144 ||| FW
polycystic  ||| S:144 E:155 ||| FW
kidney  ||| S:155 E:162 ||| FW
disease  ||| S:162 E:170 ||| FW
( ||| S:170 E:171 ||| -LRB-
ADPKD ||| S:171 E:176 ||| NNP
)  ||| S:176 E:178 ||| -RRB-
is  ||| S:178 E:181 ||| VBZ
caused  ||| S:181 E:188 ||| VBN
by  ||| S:188 E:191 ||| IN
mutations  ||| S:191 E:201 ||| NNS
in  ||| S:201 E:204 ||| IN
PKD1  ||| S:204 E:209 ||| NNP
and  ||| S:209 E:213 ||| CC
PKD2  ||| S:213 E:218 ||| NNP
and  ||| S:218 E:222 ||| CC
is  ||| S:222 E:225 ||| VBZ
characterized  ||| S:225 E:239 ||| VBN
by  ||| S:239 E:242 ||| IN
proliferation  ||| S:242 E:256 ||| NN
of  ||| S:256 E:259 ||| IN
renal  ||| S:259 E:265 ||| JJ
tubular  ||| S:265 E:273 ||| JJ
epithelium  ||| S:273 E:284 ||| NN
and  ||| S:284 E:288 ||| CC
progressive  ||| S:288 E:300 ||| JJ
chronic  ||| S:300 E:308 ||| JJ
kidney  ||| S:308 E:315 ||| NN
disease ||| S:315 E:322 ||| NN
.  ||| S:322 E:324 ||| .
Derangements  ||| S:324 E:337 ||| NNP
in  ||| S:337 E:340 ||| IN
similar  ||| S:340 E:348 ||| JJ
cellular  ||| S:348 E:357 ||| JJ
signaling  ||| S:357 E:367 ||| JJ
pathways  ||| S:367 E:376 ||| NNS
occur  ||| S:376 E:382 ||| VBP
in  ||| S:382 E:385 ||| IN
ADPKD  ||| S:385 E:391 ||| NNP
and  ||| S:391 E:395 ||| CC
renal  ||| S:395 E:401 ||| JJ
malignancies ||| S:401 E:413 ||| NN
,  ||| S:413 E:415 ||| ,
although  ||| S:415 E:424 ||| IN
an  ||| S:424 E:427 ||| DT
association  ||| S:427 E:439 ||| NN
of  ||| S:439 E:442 ||| IN
these  ||| S:442 E:448 ||| DT
disorders  ||| S:448 E:458 ||| NN
has  ||| S:458 E:462 ||| VBZ
not  ||| S:462 E:466 ||| RB
been  ||| S:466 E:471 ||| VBN
established ||| S:471 E:482 ||| VBN
.  ||| S:482 E:484 ||| .
Herein ||| S:484 E:490 ||| NNP
,  ||| S:490 E:492 ||| ,
we  ||| S:492 E:495 ||| PRP
present  ||| S:495 E:503 ||| VBP
a  ||| S:503 E:505 ||| DT
case  ||| S:505 E:510 ||| NN
of  ||| S:510 E:513 ||| IN
papillary  ||| S:513 E:523 ||| JJ
RCC  ||| S:523 E:527 ||| NNP
( ||| S:527 E:528 ||| -LRB-
pRCC ||| S:528 E:532 ||| NNP
)  ||| S:532 E:534 ||| -RRB-
incidentally  ||| S:534 E:547 ||| VBZ
discovered  ||| S:547 E:558 ||| VBN
in  ||| S:558 E:561 ||| IN
a  ||| S:561 E:563 ||| DT
patient  ||| S:563 E:571 ||| NN
with  ||| S:571 E:576 ||| IN
ADPKD  ||| S:576 E:582 ||| NNP
following  ||| S:582 E:592 ||| VBG
bilateral  ||| S:592 E:602 ||| JJ
native  ||| S:602 E:609 ||| JJ
nephrectomy  ||| S:609 E:621 ||| NN
during  ||| S:621 E:628 ||| IN
renal  ||| S:628 E:634 ||| JJ
transplantation ||| S:634 E:649 ||| NN
.  ||| S:649 E:651 ||| .
Whole  ||| S:651 E:657 ||| JJ
exome  ||| S:657 E:663 ||| JJ
sequencing  ||| S:663 E:674 ||| NN
of  ||| S:674 E:677 ||| IN
the  ||| S:677 E:681 ||| DT
pRCC  ||| S:681 E:686 ||| NN
found  ||| S:686 E:692 ||| VBD
a  ||| S:692 E:694 ||| DT
somatic  ||| S:694 E:702 ||| JJ
missense  ||| S:702 E:711 ||| JJ
mutation  ||| S:711 E:720 ||| NN
in  ||| S:720 E:723 ||| IN
MET  ||| S:723 E:727 ||| NNP
proto-oncogene ||| S:727 E:741 ||| NNP
,  ||| S:741 E:743 ||| ,
p.Val1110Ile ||| S:743 E:755 ||| NNP
,  ||| S:755 E:757 ||| ,
not  ||| S:757 E:761 ||| RB
present  ||| S:761 E:769 ||| VB
in  ||| S:769 E:772 ||| IN
kidney  ||| S:772 E:779 ||| NN
cyst  ||| S:779 E:784 ||| NN
epithelium  ||| S:784 E:795 ||| NNS
or  ||| S:795 E:798 ||| CC
non-cystic  ||| S:798 E:809 ||| JJ
tissue ||| S:809 E:815 ||| NN
.  ||| S:815 E:817 ||| .
RNA  ||| S:817 E:821 ||| NNP
sequencing  ||| S:821 E:832 ||| VBD
demonstrated  ||| S:832 E:845 ||| VBN
increased  ||| S:845 E:855 ||| VBN
mRNA  ||| S:855 E:860 ||| JJ
expression  ||| S:860 E:871 ||| NN
of  ||| S:871 E:874 ||| IN
MET  ||| S:874 E:878 ||| NNP
and  ||| S:878 E:882 ||| CC
pathway-related  ||| S:882 E:898 ||| JJ
genes ||| S:898 E:903 ||| NNS
,  ||| S:903 E:905 ||| ,
but  ||| S:905 E:909 ||| CC
no  ||| S:909 E:912 ||| DT
significant  ||| S:912 E:924 ||| JJ
copy  ||| S:924 E:929 ||| NN
number  ||| S:929 E:936 ||| NN
variation  ||| S:936 E:946 ||| NN
of  ||| S:946 E:949 ||| IN
MET  ||| S:949 E:953 ||| NNP
was  ||| S:953 E:957 ||| VBD
detected ||| S:957 E:965 ||| VBN
.  ||| S:965 E:967 ||| .
Genetic  ||| S:967 E:975 ||| JJ
analysis  ||| S:975 E:984 ||| NN
of  ||| S:984 E:987 ||| IN
PKD  ||| S:987 E:991 ||| NNP
genes  ||| S:991 E:997 ||| NNS
from  ||| S:997 E:1002 ||| IN
peripheral  ||| S:1002 E:1013 ||| JJ
blood  ||| S:1013 E:1019 ||| NN
lymphocytes  ||| S:1019 E:1031 ||| NNS
and  ||| S:1031 E:1035 ||| CC
renal  ||| S:1035 E:1041 ||| JJ
cyst  ||| S:1041 E:1046 ||| NNS
epithelium  ||| S:1046 E:1057 ||| VBP
identified  ||| S:1057 E:1068 ||| VBN
a  ||| S:1068 E:1070 ||| DT
constitutional  ||| S:1070 E:1085 ||| JJ
PKD1  ||| S:1085 E:1090 ||| CD
germline  ||| S:1090 E:1099 ||| JJ
mutation ||| S:1099 E:1107 ||| NN
,  ||| S:1107 E:1109 ||| ,
p.Trp1582Ser ||| S:1109 E:1121 ||| NNP
,  ||| S:1121 E:1123 ||| ,
predicted  ||| S:1123 E:1133 ||| VBD
to  ||| S:1133 E:1136 ||| TO
be  ||| S:1136 E:1139 ||| VB
pathogenic ||| S:1139 E:1149 ||| NNS
.  ||| S:1149 E:1151 ||| .
Unique  ||| S:1151 E:1158 ||| JJ
somatic  ||| S:1158 E:1166 ||| JJ
mutations  ||| S:1166 E:1176 ||| NNS
in  ||| S:1176 E:1179 ||| IN
PKD1  ||| S:1179 E:1184 ||| NNP
were  ||| S:1184 E:1189 ||| VBD
also  ||| S:1189 E:1194 ||| RB
detected  ||| S:1194 E:1203 ||| VBN
in  ||| S:1203 E:1206 ||| IN
80 ||| S:1206 E:1208 ||| CD
%  ||| S:1208 E:1210 ||| NN
of  ||| S:1210 E:1213 ||| IN
the  ||| S:1213 E:1217 ||| DT
renal  ||| S:1217 E:1223 ||| JJ
cysts  ||| S:1223 E:1229 ||| NN
analyzed ||| S:1229 E:1237 ||| VBD
,  ||| S:1237 E:1239 ||| ,
but  ||| S:1239 E:1243 ||| CC
not  ||| S:1243 E:1247 ||| RB
in  ||| S:1247 E:1250 ||| IN
the  ||| S:1250 E:1254 ||| DT
pRCC ||| S:1254 E:1258 ||| JJ
.  ||| S:1258 E:1260 ||| .
These  ||| S:1260 E:1266 ||| DT
results  ||| S:1266 E:1274 ||| NNS
suggest  ||| S:1274 E:1282 ||| VBP
that ||| S:1282 E:1286 ||| RB
,  ||| S:1286 E:1288 ||| ,
in  ||| S:1288 E:1291 ||| IN
this  ||| S:1291 E:1296 ||| DT
patient ||| S:1296 E:1303 ||| NN
,  ||| S:1303 E:1305 ||| ,
the  ||| S:1305 E:1309 ||| DT
pRCC  ||| S:1309 E:1314 ||| JJ
utilized  ||| S:1314 E:1323 ||| NNS
a  ||| S:1323 E:1325 ||| DT
signaling  ||| S:1325 E:1335 ||| JJ
pathway  ||| S:1335 E:1343 ||| NNS
involving  ||| S:1343 E:1353 ||| VBG
MET  ||| S:1353 E:1357 ||| NNS
that  ||| S:1357 E:1362 ||| WDT
was  ||| S:1362 E:1366 ||| VBD
distinct  ||| S:1366 E:1375 ||| JJ
from  ||| S:1375 E:1380 ||| IN
the  ||| S:1380 E:1384 ||| DT
pathogenesis  ||| S:1384 E:1397 ||| NN
of  ||| S:1397 E:1400 ||| IN
ADPKD ||| S:1400 E:1405 ||| NNP
.  ||| S:1405 E:1407 ||| .
This  ||| S:1407 E:1412 ||| DT
is  ||| S:1412 E:1415 ||| VBZ
the  ||| S:1415 E:1419 ||| DT
first  ||| S:1419 E:1425 ||| JJ
report  ||| S:1425 E:1432 ||| NN
of  ||| S:1432 E:1435 ||| IN
PKD1  ||| S:1435 E:1440 ||| CD
mutations  ||| S:1440 E:1450 ||| NNS
and  ||| S:1450 E:1454 ||| CC
a  ||| S:1454 E:1456 ||| DT
somatic  ||| S:1456 E:1464 ||| JJ
mutation  ||| S:1464 E:1473 ||| NN
of  ||| S:1473 E:1476 ||| IN
the  ||| S:1476 E:1480 ||| DT
MET  ||| S:1480 E:1484 ||| NNP
oncogene  ||| S:1484 E:1493 ||| NN
in  ||| S:1493 E:1496 ||| IN
a  ||| S:1496 E:1498 ||| DT
pRCC  ||| S:1498 E:1503 ||| JJ
in  ||| S:1503 E:1506 ||| IN
ADPKD ||| S:1506 E:1511 ||| NNP
.  ||| S:1511 E:1513 ||| .
